Table 1.
Patient characteristics
| Variables | Total population (N = 90) | |
|---|---|---|
|
Gender |
|
|
| |
Male |
49 (54.4%) |
| |
Female |
41 (45.6%) |
|
Age, years |
|
|
| |
Mean |
65.19 (SD 9.0) |
| |
≤ 50 |
5 (5.6%) |
| |
51–60 |
26 (28.9%) |
| |
61–70 |
31 (34.4%) |
| |
71–80 |
23 (25.6%) |
| |
> 80 |
5 (5.6%) |
|
Years diagnosed with COPD |
8.13 (SD8.11) |
|
|
Disease severity | ||
| |
GOLDa I |
18 (20.0%) |
| |
GOLDa II |
60 (66.7%) |
| |
GOLDa III |
12 (13.3%) |
| |
FEV1 mean |
1.86 (1.02-3.70) (SD .59) |
| |
FEV1% pred |
67.0 (36.54-101.22) (SD 14.4) |
|
Education level
b
|
|
|
| |
Low |
13 (14.4%) |
| |
Medium |
56 (62.3%) |
| |
High |
21 (23.3%) |
|
Retired |
46 (51.1%) |
|
|
Paid work |
20 (2.2%) |
|
|
Marital status |
|
|
| |
Married |
59 (65.6%) |
| |
Widowed |
8 (8.9%) |
| |
Divorced |
8 (8.9%) |
| |
Single |
15 (16.7%) |
|
Smoking status |
|
|
| |
Current smoker |
36 (40.0%) |
| |
Former smoker |
49 (54.4%) |
| |
Never smoked |
5 (5.6%) |
|
Medication use |
82 (91.1%) |
|
|
Polypharmacy
c
|
28 (31.1%) |
|
| Charlson comorbidity index >1 | 28 (31.1%) | |
aGlobal Initiative for Chronic Obstructive Lung Disease.
bCategories are based on the International Standard Classification of Education (ISCED).
cDefined by using five or more different types of medication.